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Abstract 
Purpose: Visual field assessment is an important clinical evaluation for eye disease 
and neurological injury. We evaluated Octopus semi-kinetic automated peripheral 
perimetry and Humphrey static automated central perimetry for detection of 
neurological visual field loss in patients with pituitary disease.  
Methods: Prospective cross section diagnostic accuracy study comparing Humphrey 
central 30-2 SITA threshold programme to a screening protocol for SKP on Octopus 
perimetry. Humphrey 24-2 data extracted from 30-2 results. Results independently 
graded for presence/ absence of field defect plus severity of defect.  
Results: Fifty patients (100 eyes) recruited (25 male and 25 female) with mean age 
of 52.4 years (SD15.7). Order of perimeter assessment (Humphrey/Octopus first) 
and order of eye tested (right/left first) was randomised. The 30-2 programme 
detected visual field loss in 85%, the 24-2 programme in 80% and the Octopus 
combined kinetic/static strategy in 100% of eyes. Peripheral visual field loss was 
missed by central threshold assessment. Qualitative comparison of type of visual 
field defect demonstrated a match between Humphrey and Octopus results in 58% 
with a match for severity of defect in 50%. Tests duration was 9.34 minutes (SD2.02) 
for Humphrey 30-2 versus 10.79 minutes (SD4.06) for Octopus perimetry. 
Conclusions: Octopus semi-kinetic perimetry was found to be superior to central 
static testing for detection of pituitary disease-related visual field loss. Where reliant 
on Humphrey central static perimetry, the 30-2 programme is recommended over the 
24-2 programme. Where kinetic perimetry is available, this is preferable to central 
static programmes for increased detection of peripheral visual field loss.  
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Introduction 
Perimetry is the systematic measurement of visual field function using different types 
and intensities of stimuli. Visual fields may be assessed by using moving (kinetic) 
targets which outline the boundaries of visual field or by using static (stationary on-
off) targets which map the sensitivity of the visual field.  
Pituitary tumours account for 10-15% of clinically symptomatic intracranial 
neoplasms [1] and contribute to a significant proportion of neurosurgical referrals to 
ophthalmology units. As well as visual dysfunction, complications include the effects 
of hormone hypersecretion, hypopituitarism, headaches and epilepsy [2]. The 
diagnosis of this type of lesion at an early stage is therefore of importance to the 
prognosis of the patient particularly as early intervention is of known benefit [3-6].  
The management of patients with pituitary tumours includes surgical and medical 
treatments and both have been shown to be beneficial to patients with pituitary 
tumour in terms of preservation of vision and amelioration of visual dysfunction [3-6]. 
The prompt diagnosis of this disorder, with timely and appropriate intervention when 
vision is threatened, is an important clinical consideration. 
Visual field defect is a common mode of presentation of these patients and 
knowledge of the types of visual field abnormality in patients with pituitary tumour is 
therefore important. The cause of visual field loss may be due to direct compression 
of the tumour on the anterior visual pathways and, although less direct, vascular or 
other mechanisms may also contribute [7]. The typical field defects of bitemporal 
hemianopias and quadrantanopias are known to be associated with pituitary tumour 
although other types of field defect have been described [8-13]. Elkington [2] 
reported visual field defects in 92.6% of his series with the majority (70.7%) being 
varieties of bilateral temporal loss. Rowe and colleagues [14] reported visual field 
defects in 56% of their cases with bilateral field loss being most frequent but a mix of 
temporal and nasal loss. The variability of field defects can be explained by 
compression of the chiasm, optic nerves and optic tracts or combinations of these 
structures [14]. Compression of the chiasm may be symmetrical or asymmetrical 
relating to the tumour size and its degree of extension involving the chiasm, optic 
nerve and optic tract [12]. Symmetrical or asymmetrical compression is reflected by 
the presence of bilateral or unilateral visual field defects [14]. This emphasises the 
importance of further investigation of patients presenting with field defects 
unexplained by ocular or other neurological disease.  
The assessment of loss of visual field is difficult and depends both upon the patient 
reporting their visual experience during testing, as well as the interpretation of these 
reports by a clinician. Visual fields are usually measured with perimeters such as the 
Humphrey Field AnalyserTM, Octopus perimeterTM and Goldmann perimeter. 
Although such methods do reduce the errors of interpretation and improve 
standardisation, the significant variability of such testing is still a well-recognised and 
studied phenomenon [15,16].  
Static automated perimetry has been shown to be adequate in neuro-ophthalmology 
practice while kinetic perimetry is useful for patients with severe visual and 
neurological deficits and patients with peripheral visual field defects [17,18].  In the 
context of early detection of visual involvement in pituitary tumours, it is important to 
be able to detect subtle visual field defects particularly those that arise in the 
peripheral visual field which is typically the area of visual field first compromised by 
pituitary compression. Given the advances in perimetry over recent years with the 
current availability of faster thresholding programmes and semi-automated kinetic 
programmes, the purpose of this study is to compare these methods for diagnostic 
accuracy in detecting visual field defects due to pituitary disease. Our primary aim 
was to determine whether visual field results using the Humphrey perimeter (static) 
or Octopus perimeter (kinetic and static) are equally effective in detecting subtle 
visual field loss due to neurological impairment in pituitary disease. 
 
Materials and methods 
Design 
A prospective cohort study was undertaken in accordance with the Tenets of the 
Declaration of Helsinki. Regional ethics committee and institutional Research and 
Development unit approvals were obtained. We undertook a comparative study of 
the diagnostic performance (agreement between two diagnostic tests) in two hospital 
out-patient ophthalmology units.  
Population 
The target population was patients with pituitary disease attending NHS eye clinic 
appointments for visual field assessment between April and July 2013. 
Inclusion criteria 
We included adult patients aged 18 years or older with pituitary disease requiring 
visual field assessment, sufficient motor ability to sit at the perimeter unaided, able to 
press the response button, sufficient cognitive ability to understand and follow 
instructions for performing the test, and willingness to undergo standard assessment 
on both perimeters on the same day.  
Exclusion criteria 
We excluded patients with poor reliability determined by cumulative fixation loss, 
false positive and/or false negative catch trials of greater than 25%. For kinetic 
perimetry, visual field results were deemed unreliable if patient fixation was 
considered poor by the examiner (by observation on the Octopus eye monitor) or if 
the blindspot could not be mapped. For static perimetry, visual field results were 
deemed unreliable if a score of greater than 25% was recorded for fixation losses, 
false positives and/or false negatives. We also excluded those undertaking visual 
field assessments other than 30-2 programmes, patients unable to sit for the 
duration of perimetry assessment, follow instructions for performing the test or too ill 
to complete the full assessment. 
Recruitment  
Patients with pituitary disease were recruited to assess the level of agreement for 
detection of visual field loss between the Octopus semi-kinetic automated peripheral 
perimetry and Humphrey static automated central perimetry techniques. 
We recruited patients with pituitary disease attending visual field clinics. Patients 
were required to only undergo one additional visual field assessment at one clinic 
visit. No follow-up was required. Participants were pre-selected for the study by 
identifying patients consecutively from the waiting list for visual field assessment 
during the period April to July 2014. Thus the selection procedure was not 
completely random. A selection bias existed in that the patients recruited to this 
study were booked to an out-patient visual field clinic for static perimetry. Therefore, 
there was an assumption that these patients had sufficient ability and cognition to 
undertake standard automated perimetry.  
Patients attending the visual field clinic were approached and provided with a 
participant information sheet. Once the patient had time to read the sheet, they were 
asked whether they were interested in taking part. For those willing to participate, 
they were assessed against the inclusion criteria after which informed, written 
consent was obtained. Nine patients declined to take part in the study. Reasons for 
declining to take part included a lack of time to undertake the additional test during 
the appointment. A further ten patients failed to meet the inclusion criteria. 
 Visual field assessment measures 
The Humphrey 30-2 programme and Octopus semi-kinetic perimetry option were 
used for this study. The 30-2 programme was utilised on the Humphrey perimeter. 
This programme consists of 76 stimulus locations offset from the vertical and 
horizontal meridia and interspaced by 6 degree intervals. The programme assesses 
the visual field out to 30 degrees and background illumination is set at 31.5asp. We 
wished to consider the 24-2 programme which consists of 54 stimulus locations. This 
was not assessed with our target population in this study. However the target 
locations for the 24-2 are included in the 30-2 programme. Therefore we extracted 
the data for these target locations.  
A standardised kinetic strategy17was programmed into the Octopus 900 perimeters 
used in this study such that the same programme was used across the two 
recruitment sites. Two stimuli of the same size (0.25mm2) were used but of different 
intensity (I4e, 1000 apostilbs and I2e, 100 apostilbs). The peripheral visual field 
boundary and blind spot were assessed using a size I4e target. Central visual field 
boundary was assessed using a size I2e target. A minimum of twelve vectors were 
assessed for the peripheral visual field and eight for the central visual field inclusive 
of vectors on and offset from the vertical and horizontal meridia moving centripetally, 
similar to previously reported testing strategies [17,18]. Where a visual field defect 
was found, this was further evaluated by examiner intervention using additional 
vectors with direction of target movement perpendicular to the boundary of the field 
defect. Following assessment, the response points along each vector were joined to 
form the isopter for I4e and I2e targets respectively. In addition, static points were 
assessed within the central 30 degrees of the visual field using the I4e target.  
Full (normal) visual fields by kinetic assessment were defined as visual field results 
with isopters for I4e and I2e falling within age-matched ranges (from the Octopus 
normative dataset) and no focal defects within the isopter area (apart from the blind 
spot in the temporal field). Visual field loss was defined as isopter boundaries to 
either I4e or I2e targets constricted within the age-matched ranges which could be 
global constriction or a defect type. The criteria for abnormality on Humphrey 
perimetry included MD>2dB and/or PSD value of >6dB, ≥3 contiguous points at 
p<5% forming a focal defect, glaucoma hemifield test outside normal limits or a 
combination of any two of the above.  
Classification of visual field types was according to nerve fibre layer and non-nerve 
fibre layer types [17,18]. Visual field results were also graded according to the 
degree of visual field loss, if any, and ranging from 0 (normal visual field) to 5 
(blinding visual field loss) [19]. 
The study protocol consisted of the 30-2 strategy visual field assessment and kinetic 
semi-automated visual field assessment with Humphrey perimetry and Octopus 
perimetry on the same day. The order of testing was randomised as to which of the 
two assessment types plus which eye (right/left) was undertaken first in order to take 
fatigue effect and learning effect into consideration. A short break of 5-10 minutes 
was allowed between testing on either perimeter. Age and instrument appropriate 
reading correction was used during the assessment. The assessments were 
undertaken by the same observer in each recruitment site using standardised 
computer automated programmes and therefore variability between observers is not 
assessed. 
 
Statistical analysis 
Our primary outcome measure was presence/absence of visual field loss using the 
Octopus and Humphrey perimeters. Visual field results from Humphrey and Octopus 
perimetry were assessed for presence or absence of visual field defects and for type 
and location of visual field defect as per classification options. Results of the 
evaluation of the Humphrey and Octopus methods to identify visual field loss were 
reported for the right and left eye separately and for the eyes combined. 
Level of agreement was measured using the Cohen’s kappa statistic when 
applicable (varying from 0-no agreement to 1-perfect agreement). Bearing in mind 
that the data of the right and left eye cannot be strictly regarded as independent, 
level of agreement was assessed at patient level (i.e., three categories were 
considered, mainly no visual loss, visual loss in one eye, visual loss in both eyes). 
Comparisons in grading between Octopus and Humphrey visual field scores were 
made. 
 
Results 
Equal males and females were recruited (25 males and 25 females). Mean age at 
assessment was 52.4 years (SD 15.7, range 18-83 years). Following randomization, 
48% were tested with the Humphrey perimeter first and 52% were tested with the 
Octopus perimeter first. The right eye was tested first in 56% and the left eye tested 
first in 44%. Every patient had their right and left eyes tested (100 eyes). 
 
Humphrey perimetry 
We classified visual fields for our 30-2 assessments using a binary response 
(yes/no) for presence of visual field loss. 85% were classified as having visual field 
loss present. We reclassified the visual field by excluding the peripheral test 
locations that are tested in the 30-2 programme but not in the 24-2 programme 
(figure I) to determine whether visual field loss still remained even if the 24-2 
programme had been run instead of the 30-2 programme. 80% were classified as 
having visual field loss. Thus the 24-2 programme would have missed five abnormal 
visual fields that were detected by the 30-2 programme (table IA). The classification 
by the two programmes at patient level is shown in table Ib. The non weighted 
Kappa agreement coefficient between the two programmes is 0.72, 95%CI (0.50, 
0.94). Despite this value being considered as a good level of agreement between 
methods in some studies, the wide confidence interval indicates that the level of 
precision is low. In this case, note that since the 24-2 programme is encapsulated in 
the 30-2 programme, the outcomes from each programme are not independent from 
each other. 
 
Octopus perimetry 
In order to assess whether visual field loss in pituitary damage shows a different 
level of detection when comparing peripheral stimulus and a dimmer (so potentially 
more sensitive) central stimulus, we assessed the presence/absence of visual field 
loss to either stimulus. With the I4e target, 94% were classified as having visual field 
loss present and 6% were classed as normal visual fields (table II). With the I2e 
target results 99% were classified as having visual field loss present and 1% had a 
normal visual field result. Overall, 100% were classified as having visual field loss 
present when I4e and I2e targets were combined. 
 
Humphrey and Octopus perimetry 
85% of Humphrey 30-2 results were classified as having visual field loss present 
compared to 100% of Octopus results (table IIIA). All results of visual field loss on 
Octopus perimeter were considered clinically valid based on the definition of visual 
field loss outlined in the methodology and were therefore regarded as the gold 
standard. In comparison to Octopus perimeter results the sensitivity of the Humphrey 
30-2 method is 85%. Consequently, 15% of the cases with visual field loss would be 
missed by the Humphrey 30-2 method. When the Octopus results were compared to 
the Humphrey 24-2 results, the sensitivity of the 24-2 method was 80% with, 
therefore, 20% of the cases with visual field loss were missed by this method (table 
IIIB). 
A qualitative comparison of Humphrey and Octopus results was undertaken in which 
one observer (FR) expressed an opinion of whether the visual field defect (if present) 
was depicted more clearly on either Humphrey or Octopus result or whether there 
was no difference in how clearly visual field defect was identified. The field defect 
was deemed easier to identify on Octopus in 48 results, easier to identify on 
Humphrey in 21 results with no difference in representation on either perimeter in 31 
results.  
We undertook a further qualitative comparison of whether the results from Octopus 
and Humphrey perimetry were a ‘match’ for type of visual field defect: recorded as a 
binary result of match/mismatch. 58% were deemed a match and 42% were not, e.g. 
superior defect detected by both methods (table IVA). 
Following a qualitative comparison between Octopus and Humphrey perimetry in 
severity of visual loss, only 50% of the cases were deemed a ‘match’ (table IVB). 
 
Test duration 
Duration of test per eye was recorded for both Octopus and Humphrey perimetry. 
Due to the possible effect of correlation between the left and right eye 
measurements, we performed a paired t-test on the total duration per individual for 
the Humphrey and Octopus programmes. Duration of test for Humphrey 30-2 
assessment was 9.34 minutes (SD2.02) and for Octopus kinetic assessment was 
10.79 minutes (SD4.06). The Octopus assessment was slightly longer because of 
the combined kinetic and static assessment and this was statistically significant in 
comparison to Humphrey perimetry with a difference between means of 1.44 
minutes (SD3.43, p=0.004 paired t test). 
 
Discussion 
All patients recruited to this pilot study had static threshold and kinetic perimetry 
within the same assessment visit. Types of visual field loss in pituitary disease 
typically include temporal defects (bitemporal hemianopia, bitemporal 
quadrantanopia) but also nasal visual field loss, scotomas and wedge defects [14]. 
The location and extent of visual field loss is dependent on the site of visual pathway 
compression.  
When using central threshold perimetry, commonly utilised programmes in UK clinics 
are the 30-2 and 24-2 options on the Humphrey visual field analyser and G 
programme on the Octopus perimeter. Both the 30-2 and G programmes test the 
visual field out to 30 degrees in all directions from central fixation. The 24-2 
programme tests the visual field out to 30 degrees in the nasal visual field but out to 
24 degrees only in the superior, inferior and temporal visual field. Our first objective 
was to assess whether a difference in detection of visual field loss might occur with 
use of the 24-2 rather than the 30-2 programme where fewer points are tested in the 
temporal visual field. Although overall there was a good level of agreement between 
the two programmes, the 30-2 detected visual field loss in five more eyes (5%) than 
the 24-2 option. 
Kinetic perimetry uses targets of difference size and intensity to measure the field of 
vision. Our second objective was to assess whether a difference in detection of 
visual field loss might occur with use of different target intensities (size I4e versus 
size I2e). We observed a sensitivity for detection of visual field loss of 99% by the 
I2e target and of 94% by the I4e target. When both targets were used together, the 
combination detected all visual field defects. Combined use of both targets has been 
recommended in a previous study comparing peripheral static and kinetic 
programmes [17]. 
Our third objective considered whether a difference in detection of visual field loss 
might occur with use of kinetic rather than threshold static perimetry. Visual field 
results on Octopus kinetic perimetry were compared to age-matched boundaries 
from the Octopus normative dataset. Visual field results on Humphrey static 
perimetry were compared to the age-matched thresholds from the Humphrey 
normative statpac dataset. These normative datasets are based on different 
populations so it is theoretically possible, although unlikely, that visual field defects 
may show up more clearly on comparison to one normative dataset than another. It 
is more likely that the differences relate to measurement of peripheral than purely 
central visual fields.  
Previous comparative studies have contrasted semi-kinetic perimetry using static 
perimetry within the central 30 degrees in ocular diseases such as advanced 
glaucoma, optic neuritis and optic nerve head drusen. These studies have reported 
good comparisons and test-retest reliability [12,20-24]. Similar comparisons for 
neuro-ophthalmic cases have been reported with equal reliability in 77% of eyes [25]. 
In our study with the 30-2 programme assessment, 85% of results showed visual 
field loss and 15% were normal with full central visual fields. With kinetic 
assessment, 100% of results showed visual field loss. Thus 15% of results with 
peripheral visual field loss were missed by central threshold assessment which was 
statistically significant. This is clinically important as pituitary disease can cause 
peripheral visual field loss and early diagnosis is essential to allow prompt 
intervention. In this study we did not undertake a peripheral static testing 
programme. A previous study compared the Humphrey peripheral static screening 
programme (full field 120) to an Octopus peripheral kinetic strategy [18]. A match for 
normal or abnormal visual field results was reported for 87% of the cases. The 
authors concluded that although the FF120 was useful for detection of visual field 
defects, Octopus kinetic perimetry was preferable as it provided added information of 
the defect depth and size plus a more representative view of the visual field defect 
[18].  
Visual field results are displayed quite differently between kinetic and threshold 
programmes and, given the potential for stato-kinetic dissociation (where static 
results appear worse than kinetic results [26]), we considered whether either method 
displayed the visual field result more clearly than the other. This was determined 
purely by a qualitative evaluation of each visual field result from either perimeter as 
described previously [19].In 42% of the assessments there was a difference in the 
grading of visual field defect observed between Octopus and Humphrey (30-2 
programme). Mis-match of visual field results typically related to differences in 
normal versus functional, superior defect or vertical step results, and more extensive 
visual fields on one perimeter result such as hemianopia depicted on one result with 
inferior or superior defect on the other. This has been similarly reported previously 
[18]. In relation to pituitary disease, 2.6% had normal Humphrey results but 
corresponding Octopus results showed peripheral superior defects. Octopus 
perimetry was twice as likely to show a clearer representation of the visual field than 
Humphrey perimetry. On comparing severity of field loss, 50% were graded equally 
as having the same severity of defect on either perimeter. A difference of one grade, 
e.g. minimal versus mild and mild versus moderate, was found for 33%; 13% in 
which the Humphrey result was normal but the Octopus result showed a mild visual 
field defect. A difference of two grades, e.g. minimal versus moderate and mild 
versus marked was found for 15%; 7% in which the Humphrey result was normal but 
the Octopus result showed a mild visual field defect. Such differences are clinically 
significant but mainly represent the presence of a peripheral visual field defect found 
on Octopus perimetry which was not/less evident on the central programme from 
Humphrey perimetry. We acknowledge that these clinical grades of mis-match of 
visual fields for visual field defect type and severity are purely based on qualitative 
evaluation where there is the potential for observer bias, similar to the reported 
literature [17,18,27,28]. 
 
Conclusions 
There is clinical significance to detection of visual field loss in pituitary disease and 
capturing peripheral loss is important to the early diagnosis of chiasmal involvement. 
Based on our results, we recommend that, where central threshold perimetry is 
conducted on patients with pituitary disease, the full 30 degrees is tested and 
programmes such as the 24-2 option are avoided. Where it is possible to measure 
kinetic peripheral visual fields, this is preferable to static central visual fields for 
increased detection of peripheral visual field loss. When conducting kinetic 
perimetry, the combined use of peripheral (I4e) and central (I2e) targets increases 
sensitivity to detection of visual field loss.  
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Figure I  30-2 minus 24-2 peripheral points 
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Legend (figure 1): This is an example for the right eye showing the stimulus 
locations points for the 30-2 and 24-2 threshold programmes. ● indicates points seen 
on both 30-2 and 24-2 programmes. ○ indicates points seen only on the 30-2 
programme but omitted from testing on the 24-2 programme. 
 
  
Table I Humphrey 30-2 and 24-2 strategy responses 
A: Detection of visual loss 
 
  Humphrey30-2 
  Left Eye Right Eye Both Eyes 
  
Visual 
loss 
No 
visual 
loss 
Total 
Visual 
loss 
No 
visual 
loss 
Total 
Visual 
loss 
No 
visual 
loss 
Total 
Humphrey 
Visual 
loss 
39 0 39 41 0 41 80 0 80 
24-2 
No 
visual 
loss 
3 8 11 2 7 9 5 15 20 
Total 
 
42 8 50 43 7 50 85 15 100 
 
B: Strategy responses at patient level for the four programmes 
 
Method   Humphrey Octopus 
 
Sub-
Method 
 24-2 30-2 I2e I4e Overall 
  
Visual Loss 
(Eyes) 
0 1 2 0 1 2 0 1 2 0 1 2 0 1 2 
Humphrey 
24-2 
0 - - - 7 0 0 0 1 6 2 0 5 0 0 7 
1 - - - 0 1 5 0 0 6 0 1* 5 0 0 6 
2 - - - 0 0 37 0 0 37 0 1 36 0 0 37 
30-2 
0 7 0 0 - - - 0 1 6 2 0 5 0 0 7 
1 0 1 0 - - - 0 0 1 0 0 1 0 0 1 
2 0 5 37 - - - 0 0 42 0 2 40 0 0 42 
Octopus 
I2e 
0 0 0 0 0 0 0 - - - 0 0 0 0 0 0 
1 1 0 0 1 0 0 - - - 0 0 1 0 0 1 
2 6 6 37 6 1 42 - - - 2 2 45 0 0 49 
I4e 
0 2 0 0 2 0 0 0 0 2 - - - 0 0 2 
1 0 1 1 0 0 2 0 0 2 - - - 0 0 2 
2 5 5 36 5 1 40 0 1 45 - - - 0 0 46 
Overall 
0 0 0 0 0 0 0 0 0 0 0 0 0 - - - 
1 0 0 0 0 0 0 0 0 0 0 0 0 - - - 
2 7 6 37 7 1 42 0 1 49 2 2 46 - - - 
Visual loss (eyes): 0-no visual loss, 1-visual loss in one eye, 2-visual loss in both eyes 
* Humphrey 24_2 and 4e Octopus found visual loss in different eyes. 
  
Table II Octopus I4e and I2e strategy responses 
 
 I2e target 
  Left Eye Right Eye Both Eyes 
Visual 
loss 
No 
visual 
loss 
Total Visual 
loss 
No 
visual 
loss 
Total Visual 
loss 
No 
visual 
loss 
Total 
 
 
Visual 
loss 
46 1 47 47 0 47 93 1 94 
I4e target No 
visual 
loss 
3 0 3 3 0 3 6 0 6 
 Total 
 
49 1 50 50 0 50 99 1 100 
 
  
Table III Humphrey and Octopus perimetry responses 
A: 30-2 versus Octopus 
 Humphrey 30-2 
 Left Eye Right Eye Both Eyes 
Visual 
loss 
No 
visual 
loss 
Total Visual 
loss 
No 
visual 
loss 
Total Visual 
loss 
No 
visual 
loss 
Total 
 Visual 
loss 
42 8 50 43 7 50 85 15 100 
Octopus No 
visual 
loss 
0 0 0 0 0 0 0 0 0 
 Total 42 8 50 43 7 50 85 15 100 
 
B: 24-2 versus Octopus 
 Humphrey 24-2 
      
 
Left Eye Right Eye Both Eyes 
Visual 
loss 
No 
visual 
loss 
Total Visual 
loss 
No 
visual 
loss 
Total Visual 
loss 
No 
visual 
loss 
Total 
Octopus Visual 
loss 
39 11 50 41 9 41 80 20 100 
 No 
visual 
loss 
0 0 0 0 0 0 0 0 0 
 Total 39 11 50 41 9 41 80 20 100 
 
  
Table IV Grading of visual field defect 
A: Type of visual field defect 
 
 
 
 
 
 
 
 
 
 
Humphre
y field 
defect 
type 
                                                                       Octopus field defect type Tota
l 
 Norma
l 
Arcuat
e 
Functiona
l 
Homonymou
s hemianopia 
Bitemporal 
hemianopi
a 
Inferio
r 
defect 
Inferior 
quadrantanopi
a 
Superio
r defect 
Increase
d blind 
spot 
Vertica
l step 
 
Normal 1 0 7 0 0 0 0 9 0 4 21 
Arcuate 0 0 3 0 0 0 0 0 0 0 3 
Functional 0 0 9 0 0 0 0 1 0 0 10 
Homonymous 
hemianopia 
0 0 0 1 0 0 0 0 0 0 1 
Bitemporal 
hemianopia 
0 0 1 0 14 0 0 4 0 1  20 
Inferior defect 0 0 1 0 1 2 0 0 0 0 4 
Inferior 
quadrantanopi
a 
0 0 0 0 0 0 0 2 0 0 2 
Superior 
defect 
0 0 3 0 0 0 0 31 0 0 34 
Increased 
blind spot 
0 0 0 0 0 0 0 3 0 2 5 
Vertical step 0 0 0 0 0 0 0 0 0 0 0 
 1 0 24 1 15 2 0 50 0 7 100 
 
B: Severity of visual field defect 
 
  Octopus field grade Total 
Normal Minimal Mild Moderate Marked Blinding 
Humphrey field 
grade 
Normal 1 13 7 0 2 0 23 
Minimal 0 24 2 2 0 0 28 
Mild 0 9 11 1 0 0 21 
Moderate 0 3 4 7 0 0 14 
Marked 0 0 3 3 5 1 12 
Blinding 0 0 0 0 0 2 2 
Total 1 49 27 13 7 3 100 
 
 
 
 
 
